Literature DB >> 30354510

Alirocumab's Price Reduction.

Sanket S Dhruva1,2, Joseph S Ross1,3,4,5, Nihar R Desai6,5.   

Abstract

Keywords:  cardiovascular diseases; cost-benefit analysis; costs and cost analysis; insurance, health, reimbursement; outcome and process assessment (health care)

Mesh:

Substances:

Year:  2018        PMID: 30354510     DOI: 10.1161/CIRCULATIONAHA.118.036069

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  1 in total

Review 1.  The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice.

Authors:  Merilyn S Varghese; Chia-Liang Liu; Dhruv S Kazi
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.